Post-metastasis survival in high-risk localised and locally advanced prostate cancer patients undergoing primary treatment in the United States: A retrospective study

2023

Freedland S, Fernandes L, De Solda F, Buyukkaramikli N, Mundle SD, McCarthy SA, Labson D, Yang L, Pan F, Mir C